CANCER 6
through routine testing with the PSA test. Treatment alternatives differ depending on stage, age
and grade of cancer, on top of other medical conditions (Cyllene, 2010).
Drugs Approved For Lung, Breast, Prostate, Colon And Rectal Cancer.
Abraxane is particularly designated for the early treatment of locally progressed or
metastatic non-small cell lung cancer, in an amalgamation with carboplatin, in cancer patients
who are not entrants for radiation therapy or curative surgery. Side effects include anemia,
nausea and fatigue(National Cancer Institute, 2012).
Afinitor is exclusively approved for the cure of postmenopausal women with advanced
hormone receptor-positive, HER2-negative breast cancer (advanced HR+ BC) in an
amalgamation with exemestane, following failure of treatment with letrozole or anastrozole. The
side effects are mainly fatigue, diarrhea, edema, abdominal pain, alopecia and nausea(National
Cancer Institute, 2012).
Xtandi is specially designated for the treatment of individuals with metastatic castration-
resistant prostate cancer who have beforehand obtained docetaxel. Some of the side effects
include asthenia/fatigue, back pain, diarrhea, and arthralgia.(National Cancer Institute, 2012)
Zaltrap (ziv-aflibercept) is exploited in colorectal cancer treatment, is a blending protein
exclusively crafted to attach all varities of Vascular Endothelial Growth Factor-A (VEGF-A) and
Placental Growth Factor (PlGF). Both PlGF and VEGF-A are proteins that participate in the
abnormal formation of new blood vessels. Its side effects are weight loss, diarrhea, stomatitis and
headache. All these drugs were approved by Food and Drug Administration (FDA) in
2012(National Cancer Institute, 2012).
Non-Hodgkin’s Lymphoma Chemotherapy